Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro

Mooyottu S, Flock G, Venkitanarayanan K Journal of Medical Microbiology, 2017 PURPOSE: Clostridium difficile is an anaerobic spore-forming pathogen that causes a serious toxin-mediated enteric disease in humans. Therapeutic agents that are capable of reducing C. difficile spore production could significantly minimize the transmission and relapse of C. difficile infections. This study investigated the efficacy… Read more »